Send
Print
Myfuture.com via flickr
According to the newspaper, the plan included intensification of work on vaccines and their approval in the framework of the Innovative Medicines Initiative partnership. The Board of Governors of the Innovative Medicines Initiative includes representatives from the European Commission and the European Federation of the Pharmaceutical Industry, which are attended by major global pharmaceutical companies such as GlaxoSmithKline, Novartis, Pfizer, Lilly and Johnson & Johnson.
The European Commission argued that these vaccines should have been developed and approved before possible outbreaks of a disease, but this idea did not find support in pharmaceutical companies.
According to The Guardian, the situation in 2017 is described in a report by the Corporate Observatory Europe Brussels Research Center. The document analyzes decisions made within the framework of the Innovative Medicines Initiative.
The Guardian notes that due to the unpreparedness for the coronavirus pandemic, the pharmaceutical industry has recently been accused of failing to prioritize the fight against infectious diseases as it is less profitable than the fight against chronic diseases.
Eight vaccines, which may be suitable for controlling coronavirus, are currently undergoing clinical trials, but none of them offer guarantees of success. The Guardian calls a vaccine, which is being developed by specialists at Oxford University, the most promising, but it also has only a 50% chance of being approved for clinical use.
source: theguardian.com
The European Commission argued that these vaccines should have been developed and approved before possible outbreaks of a disease, but this idea did not find support in pharmaceutical companies.
According to The Guardian, the situation in 2017 is described in a report by the Corporate Observatory Europe Brussels Research Center. The document analyzes decisions made within the framework of the Innovative Medicines Initiative.
The Guardian notes that due to the unpreparedness for the coronavirus pandemic, the pharmaceutical industry has recently been accused of failing to prioritize the fight against infectious diseases as it is less profitable than the fight against chronic diseases.
Eight vaccines, which may be suitable for controlling coronavirus, are currently undergoing clinical trials, but none of them offer guarantees of success. The Guardian calls a vaccine, which is being developed by specialists at Oxford University, the most promising, but it also has only a 50% chance of being approved for clinical use.
source: theguardian.com
